Notes / Company

Metropolis Healthcare Ltd.

METROPOLIS BSE 542650 ISIN INE112L01020 Diagnostics

Fundamentals

Market cap: ₹11,265 cr
P/E: 59.29×
ROE: 10.89%
Debt / equity: 0.01
Div yield: 0.23%
52-week range: 412.25 — 600.00

Research on Tijori Finance

Company snapshot

Metropolis Healthcare Ltd.

Diagnostic Chains

₹11,521 cr

P/E 60.63×

Latest quarter · Mar 2026

Sales₹425 cr

Net profit₹51 cr

Op. margin+25.4%

EPS₹2.46

Strength & growth

Debt / equity0.01×

Current ratio1.11×

Sales CAGR+11.7%

EPS CAGR+6.6%

The timeline — 1 note on Metropolis Healthcare Ltd.

July 2026

05 Jul 26 · 12:13 PM IST Brief

Brief · Mid cap

Metropolis Q1 revenue up ~16% but growth slows from Q4's 23.6%

Wellness and specialty segments drive volumes; EBITDA margins improve YoY and stay stable sequentially. Full results await board approval.

Verify on exchange BSE filings for METROPOLIS NSE filings for METROPOLIS Tijori Finance company page